Search Results - "Shargh, Vahid Heravi"

Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends by Badiee, Ali, Heravi Shargh, Vahid, Khamesipour, Ali, Jaafari, Mahmoud Reza

“…Highlights ► A suitable adjuvant is needed to improve the efficacy of antileishmanial vaccines. ► Particulate adjuvants are the valuable strategy to enhance…”
Get full text

Antibody-targeted biodegradable nanoparticles for cancer therapy by Shargh, Vahid Heravi, Hondermarck, Hubert, Liang, Mingtao

“…The use of nanotechnology has great potentials to revolutionize the future cancer diagnosis and therapy. In this context, various nanoparticles (NPs) have been…”
Get full text

Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy by Shargh, Vahid Heravi, Hondermarck, Hubert, Liang, Mingtao

“…To develop matrix metalloproteinase-responsive gelatin-albumin hybrid nanoparticles encapsulating a selective tropomyosin receptor kinase A (TrkA) inhibitor…”
Get full text

Surface-modified cationic liposomes with a matrix metalloproteinase-degradable polyethylene glycol derivative improved doxorubicin delivery in murine colon cancer by Askarizadeh, Anis, Mashreghi, Mohammad, Mirhadi, Elaheh, Mehrabian, Amin, Heravi Shargh, Vahid, Badiee, Ali, Alavizadeh, Seyedeh Hoda, Arabi, Leila, Kamali, Hossein, Jaafari, Mahmoud Reza

“…PEGylation is a commonly used approach to prolong the blood circulation time of cationic liposomes. However, PEGylation is associated with the "PEG dilemma",…”
Get full text

Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue by Heravi Shargh, Vahid, Luckett, Jeni, Bouzinab, Kaouthar, Paisey, Stephen, Turyanska, Lyudmila, Singleton, William G. B, Lowis, Stephen, Gershkovich, Pavel, Bradshaw, Tracey D, Stevens, Malcolm F. G, Bienemann, Alison, Coyle, Beth

“…The lack of clinical response to the alkylating agent temozolomide (TMZ) in pediatric diffuse midline/intrinsic pontine glioma (DIPG) has been associated with…”
Get full text

Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model by Jafari, Iman, Heravi Shargh, Vahid, Shahryari, Maryam, Abbasi, Azam, Jaafari, Mahmoud Reza, Khamesipour, Ali, Badiee, Ali

“…Although there have been numerous attempts to develop a successful vaccine against leishmaniasis, based on the clinical trial in this field, no vaccine against…”
Get full text

Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA) by Firouzmand, Hengameh, Badiee, Ali, Khamesipour, Ali, Heravi Shargh, Vahid, Alavizadeh, Seyedeh Hoda, Abbasi, Azam, Jaafari, Mahmoud Reza

“…•DOTAP nanoliposomes containing 1mg/ml of SLA induce an efficient protection against leishmaniasis.•DOTAP nanoliposomes containing 1mg/ml of SLA reduce lesion…”
Get full text

Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy by Askarizadeh, Anis, Mashreghi, Mohammad, Mirhadi, Elaheh, Mirzavi, Farshad, Shargh, Vahid Heravi, Badiee, Ali, Alavizadeh, Seyedeh Hoda, Arabi, Leila, Jaafari, Mahmoud Reza

“…Background Colorectal cancer is one of the prominent leading causes of fatality worldwide. Despite recent advancements within the field of cancer therapy, the…”
Get full text

The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen by Badiee, Ali, Khamesipour, Ali, Samiei, Afshin, Soroush, Dina, Shargh, Vahid Heravi, Kheiri, Masoumeh Tavassoti, Barkhordari, Farzaneh, Robert Mc Master, W., Mahboudi, Fereidoun, Jaafari, Mahmoud R.

“…[Display omitted] ► Liposome’s size plays a significant role in the type of generated immune response. ► A liposomal delivery system was developed to induce…”
Get full text

Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis by Heravi Shargh, Vahid, Jaafari, Mahmoud Reza, Khamesipour, Ali, Jalali, Seyed Amir, Firouzmand, Hengameh, Abbasi, Azam, Badiee, Ali

“…Development of an effective vaccine against leishmaniasis is possible due to the fact that individuals cured from cutaneous leishmaniasis (CL) are protected…”
Get full text

Albumin hybrid nanoparticles loaded with tyrosine kinase A inhibitor GNF-5837 for targeted inhibition of breast cancer cell growth and invasion by Shargh, Vahid Heravi, Hondermarck, Hubert, Liang, Mingtao

“…Delivery of poorly soluble GNF-5837 via albumin hybrid nanoparticles (GNF-Alb-HNPs) shows significantly superior anticancer efficacy in a panel of breast…”
Get full text

Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis by Shargh, Vahid Heravi, Jaafari, Mahmoud Reza, Khamesipour, Ali, Jaafari, Iman, Jalali, Seyed Amir, Abbasi, Azam, Badiee, Ali

“…Highlights ► The nuclease-resistant (PS) or -sensitive (PO) CpG ODNs were used as adjuvants. ► A liposomal delivery system was developed to protect PO CpG ODNs…”
Get full text